Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Other Working Capital Changes (2016 - 2025)

Capricor Therapeutics has reported Other Working Capital Changes over the past 14 years, most recently at $3.3 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $3.3 million for Q4 2025, up 394.16% from a year ago — trailing twelve months through Dec 2025 was $4.1 million (up 114.31% YoY), and the annual figure for FY2025 was $4.1 million, up 699.78%.
  • Other Working Capital Changes for Q4 2025 was $3.3 million at Capricor Therapeutics, up from $966329.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for CAPR hit a ceiling of $30.0 million in Q1 2022 and a floor of -$28.6 million in Q4 2022.
  • Median Other Working Capital Changes over the past 5 years was $240117.0 (2024), compared with a mean of $474994.9.
  • Peak annual rise in Other Working Capital Changes hit 113107.55% in 2022, while the deepest fall reached 3351.71% in 2022.
  • Capricor Therapeutics' Other Working Capital Changes stood at $881028.0 in 2021, then plummeted by 3351.71% to -$28.6 million in 2022, then soared by 104.07% to $1.2 million in 2023, then tumbled by 196.97% to -$1.1 million in 2024, then skyrocketed by 394.16% to $3.3 million in 2025.
  • The last three reported values for Other Working Capital Changes were $3.3 million (Q4 2025), $966329.0 (Q3 2025), and -$229917.0 (Q2 2025) per Business Quant data.